Humanized antibodies against vascular endothelial growth factor

Details for Australian Patent Application No. 2004295339 (hide)

Owner Abmaxis, Inc.

Inventors Li, Yan; Wang, Kevin C.; Zhong, Pingyu; Luo, Peizhi; Hsieh, Mark

Agent Shelston IP

Pub. Number AU-A-2004295339

PCT Pub. Number WO2005/054273

Priority 10/723,434 26.11.03 US

Filing date 22 November 2004

Wipo publication date 16 June 2005

International Classifications

A61K 39/395 (2006.01) Medicinal preparations containing antigens or antibodies - Antibodies

Event Publications

22 June 2006 PCT application entered the National Phase

  PCT publication WO2005/054273 Priority application(s): WO2005/054273

14 June 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2004295342-Derivatives of dihydronepetalactone and method for preparation

2004295331-Method of forming thermoplastic foams using nano-particles to control cell morphology